Age, leukocytosis, cardiovascular risk factors, JAK2 V617F mutation and other high-risk mutations were identified as significant predictors of arterial thrombosis in these patients; the only predictor of venous thrombosis was a history of thrombosis, particularly venous thrombosis. The gene discussed is JAK2; the disease is Venous thrombosis.